Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milton

Showing results (341-350 of 11,966) with videos related to

Pageof 1,197
Sort By:
Transcultural Psychiatry|January 15, 2015
Training international medical graduates in psychiatry: a cultural adventureMilton Kramer
The New England Journal of Medicine|December 12, 2019
Why Are Physicians So Confused about Acute Heart Failure?. ReplyMilton Packer
Diabetes, Obesity & Metabolism|January 10, 2020
Interplay of adenosine monophosphate-activated protein kinase/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A novel conceptual frameworkMilton Packer
Diabetes Research and Clinical Practice|January 20, 2020
Concerns about the use of metformin as a first-line agent to slow the progression of chronic kidney disease in diabetesMilton Packer
European Journal of Heart Failure|October 31, 2017
Will long-acting glucagon-like peptide-1 analogues recapitulate our agonizing experience with cyclic AMP-dependent positive inotropic agents in heart failure?Milton Packer
European Journal of Heart Failure|February 2, 2018
Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trialMilton Packer
Cardiovascular Research|April 4, 2020
Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stressMilton Packer
European Heart Journal|May 24, 2019
Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journeyMilton Packer
Journal of Cardiovascular Electrophysiology|October 19, 2019
Heightened risk of intensive rate control in patients with atrial fibrillation who are obese or have type 2 diabetes: A critical review and re-evaluationMilton Packer
Diabetes, Obesity & Metabolism|May 31, 2019
Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetesMilton Packer
Pageof 1,197

Showing results (341-350 of 11,966) with videos related to

Sort By:
Pageof 1,197
Transcultural Psychiatry|January 15, 2015
Training international medical graduates in psychiatry: a cultural adventureMilton Kramer
The New England Journal of Medicine|December 12, 2019
Why Are Physicians So Confused about Acute Heart Failure?. ReplyMilton Packer
Diabetes, Obesity & Metabolism|January 10, 2020
Interplay of adenosine monophosphate-activated protein kinase/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A novel conceptual frameworkMilton Packer
Diabetes Research and Clinical Practice|January 20, 2020
Concerns about the use of metformin as a first-line agent to slow the progression of chronic kidney disease in diabetesMilton Packer
European Journal of Heart Failure|October 31, 2017
Will long-acting glucagon-like peptide-1 analogues recapitulate our agonizing experience with cyclic AMP-dependent positive inotropic agents in heart failure?Milton Packer
European Journal of Heart Failure|February 2, 2018
Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trialMilton Packer
Cardiovascular Research|April 4, 2020
Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stressMilton Packer
European Heart Journal|May 24, 2019
Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journeyMilton Packer
Journal of Cardiovascular Electrophysiology|October 19, 2019
Heightened risk of intensive rate control in patients with atrial fibrillation who are obese or have type 2 diabetes: A critical review and re-evaluationMilton Packer
Diabetes, Obesity & Metabolism|May 31, 2019
Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetesMilton Packer
Pageof 1,197